XML 45 R6.htm IDEA: XBRL DOCUMENT
v3.20.4

Financial Statements - Statements of changes in equity - EUR (€) | Total | Capital | Share premium (*) | Equity instruments issued other than capital | Other Equity | Retained earnings | Revaluation reserves | Other reserves | Treasury shares [Member] | Profit or loss attributable to owners of the parent Member | Interim dividends Member | Accumulated other Comprehensive Income [Member] | Non-Controlling interests- Valuation Adjustments | Non-Controlling interests- Rest | Total Member
--- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | ---
Balance at beginning at Dec. 31, 2017 |  |  |  | € 3,267,000,000 |  | € 23,992,000,000 |  | € 0 |  | € 54,000,000 |  | € 25,474,000,000 |  | € 12,000,000 |  | € (44,000,000) |  | € (96,000,000) |  | € 3,519,000,000 |  | € (1,043,000,000) |  | € (8,792,000,000) |  | € (3,378,000,000) |  | € 10,358,000,000 |  | € 53,323,000,000 |
Changes in Equity Abstract |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Adjustments Of Accounting Policies Applications | [1] |  |  | 0 |  | 0 |  | 0 |  | 0 |  | 348,000,000 |  | 0 |  | 30,000,000 |  | 0 |  | (5,000,000) |  | (129,000,000) |  | (1,192,000,000) |  | (1,181,000,000) |  | 1,209,000,000 |  | (919,000,000) |
TOTAL RECOGNIZED INCOME/EXPENSES |  | € 3,622,000,000 | [1] | 0 | [2] | 0 | [2] | 0 | [2] | 0 | [2] | 0 | [2] | 0 | [2] | 0 | [2] | 0 | [2] | 5,400,000,000 | [2] | 0 | [2] | (1,335,000,000) | [2] | (1,270,000,000) | [2] | 827,000,000 | [2] | 3,622,000,000 | [2]
Changes in equity |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Total Changes in Equity | [2] |  |  | 0 |  | 0 |  | 0 |  | (4,000,000) |  | 240,000,000 |  | (10,000,000) |  | (24,000,000) |  | (199,000,000) |  | (3,514,000,000) |  | 63,000,000 |  | 1,096,000,000 |  | 540,000,000 |  | (1,341,000,000) |  | (3,152,000,000) |
Issue Of Equity | [2] |  |  | 0 |  | 0 |  | 0 |  | 0 |  | 0 |  | 0 |  | 0 |  | 0 |  | 0 |  | 0 |  | 0 |  | 0 |  | 0 |  | 0 |
Issuances of preferred shares | [2] |  |  | 0 |  | 0 |  | 0 |  | 0 |  | 0 |  | 0 |  | 0 |  | 0 |  | 0 |  | 0 |  | 0 |  | 0 |  | 0 |  | 0 |
Issuance of other equity instruments | [2] |  |  | 0 |  | 0 |  | 0 |  | 0 |  | 0 |  | 0 |  | 0 |  | 0 |  | 0 |  | 0 |  | 0 |  | 0 |  | 0 |  | 0 |
Period or maturity of other issued equity instruments | [2] |  |  | 0 |  | 0 |  | 0 |  | 0 |  | 0 |  | 0 |  | 0 |  | 0 |  | 0 |  | 0 |  | 0 |  | 0 |  | 0 |  | 0 |
Conversion of debt on equity | [2] |  |  | 0 |  | 0 |  | 0 |  | 0 |  | 0 |  | 0 |  | 0 |  | 0 |  | 0 |  | 0 |  | 0 |  | 0 |  | 0 |  | 0 |
Common Stock reduction | [2] |  |  | 0 |  | 0 |  | 0 |  | 0 |  | 0 |  | 0 |  | 0 |  | 0 |  | 0 |  | 0 |  | 0 |  | 0 |  | 0 |  | 0 |
Dividend distribution | [2] |  |  | 0 |  | 0 |  | 0 |  | 0 |  | (996,000,000) |  | 0 |  | 0 |  | 0 |  | 0 |  | (1,109,000,000) |  | 0 |  | 0 |  | (378,000,000) |  | (2,483,000,000) |
Purchase of treasury shares | [2] |  |  | 0 |  | 0 |  | 0 |  | 0 |  | 0 |  | 0 |  | 0 |  | (1,684,000,000) |  | 0 |  | 0 |  | 0 |  | 0 |  | 0 |  | (1,684,000,000) |
Sale or cancellation of treasury shares | [2] |  |  | 0 |  | 0 |  | 0 |  | 0 |  | (24,000,000) |  | 0 |  | 0 |  | 1,484,000,000 |  | 0 |  | 0 |  | 0 |  | 0 |  | 0 |  | 1,460,000,000 |
Reclassification of financial liabilities to other equity instruments | [2] |  |  | 0 |  | 0 |  | 0 |  | 0 |  | 0 |  | 0 |  | 0 |  | 0 |  | 0 |  | 0 |  | 0 |  | 0 |  | 0 |  | 0 |
Reclassification of other equity instruments to financial liabilities | [2] |  |  | 0 |  | 0 |  | 0 |  | 0 |  | 0 |  | 0 |  | 0 |  | 0 |  | 0 |  | 0 |  | 0 |  | 0 |  | 0 |  | 0 |
Transfers between total equity entries | [2] |  |  | 0 |  | 0 |  | 0 |  | 0 |  | 1,278,000,000 |  | (10,000,000) |  | (23,000,000) |  | 0 |  | (3,514,000,000) |  | 1,172,000,000 |  | 1,096,000,000 |  | 540,000,000 |  | (540,000,000) |  | 0 |
Increase/Reduction of equity due to business combinations | [2] |  |  | 0 |  | 0 |  | 0 |  | 0 |  | 0 |  | 0 |  | 0 |  | 0 |  | 0 |  | 0 |  | 0 |  | 0 |  | 0 |  | 0 |
Share based payments | [2] |  |  | 0 |  | 0 |  | 0 |  | (19,000,000) |  | 0 |  | 0 |  | 0 |  | 0 |  | 0 |  | 0 |  | 0 |  | 0 |  | 0 |  | (19,000,000) |
Other increases or (-) decreases in equity | [2] |  |  | 0 |  | 0 |  | 0 |  | 15,000,000 |  | (17,000,000) |  | 0 |  | (1,000,000) |  | 0 |  | 0 |  | 0 |  | 0 |  | 0 |  | (423,000,000) |  | (426,000,000) |
Balance at the end at Dec. 31, 2018 |  | 52,874,000,000 |  | 3,267,000,000 | [3],[4] | 23,992,000,000 | [3],[4] | 0 | [3],[4] | 50,000,000 | [3],[4] | 23,017,000,000 | [3],[4] | 3,000,000 | [3],[4] | (57,000,000) | [3],[4] | (296,000,000) | [3],[4] | 5,324,000,000 | [3],[4] | (975,000,000) | [3],[4] | (7,215,000,000) | [3],[4] | (3,236,000,000) | [3],[4] | 9,000,000,000 | [3],[4] | 52,874,000,000 | [3],[4]
Changes in Equity Abstract |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Adjustments Of Accounting Policies Applications | [5] |  |  | 0 |  | 0 |  | 0 |  | 0 |  | 3,045,000,000 |  | 0 |  | 20,000,000 |  | 0 |  | 76,000,000 |  | (134,000,000) |  | (3,007,000,000) |  | (2,054,000,000) |  | 2,054,000,000 |  | 0 |
TOTAL RECOGNIZED INCOME/EXPENSES | [5] | 4,060,000,000 |  | 0 |  | 0 |  | 0 |  | 0 |  | 0 |  | 0 |  | 0 |  | 0 |  | 3,512,000,000 |  | 0 |  | (3,000,000) |  | (282,000,000) |  | 833,000,000 |  | 4,060,000,000 |
Changes in equity |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Total Changes in Equity | [5] |  |  | 0 |  | 0 |  | 0 |  | 6,000,000 |  | 3,326,000,000 |  | (3,000,000) |  | (82,000,000) |  | 234,000,000 |  | (5,400,000,000) |  | 25,000,000 |  | 0 |  | 0 |  | (115,000,000) |  | (2,009,000,000) |
Issue Of Equity | [5] |  |  | 0 |  | 0 |  | 0 |  | 0 |  | 0 |  | 0 |  | 0 |  | 0 |  | 0 |  | 0 |  | 0 |  | 0 |  | 0 |  | 0 |
Issuances of preferred shares | [5] |  |  | 0 |  | 0 |  | 0 |  | 0 |  | 0 |  | 0 |  | 0 |  | 0 |  | 0 |  | 0 |  | 0 |  | 0 |  | 0 |  | 0 |
Issuance of other equity instruments | [5] |  |  | 0 |  | 0 |  | 0 |  | 0 |  | 0 |  | 0 |  | 0 |  | 0 |  | 0 |  | 0 |  | 0 |  | 0 |  | 0 |  | 0 |
Period or maturity of other issued equity instruments | [5] |  |  | 0 |  | 0 |  | 0 |  | 0 |  | 0 |  | 0 |  | 0 |  | 0 |  | 0 |  | 0 |  | 0 |  | 0 |  | 0 |  | 0 |
Conversion of debt on equity | [5] |  |  | 0 |  | 0 |  | 0 |  | 0 |  | 0 |  | 0 |  | 0 |  | 0 |  | 0 |  | 0 |  | 0 |  | 0 |  | 0 |  | 0 |
Common Stock reduction | [5] |  |  | 0 |  | 0 |  | 0 |  | 0 |  | 0 |  | 0 |  | 0 |  | 0 |  | 0 |  | 0 |  | 0 |  | 0 |  | 0 |  | 0 |
Dividend distribution | [5] |  |  | 0 |  | 0 |  | 0 |  | 0 |  | (1,063,000,000) |  | 0 |  | 0 |  | 0 |  | 0 |  | (1,084,000,000) |  | 0 |  | 0 |  | (142,000,000) |  | (2,289,000,000) |
Purchase of treasury shares | [5] |  |  | 0 |  | 0 |  | 0 |  | 0 |  | 0 |  | 0 |  | 0 |  | (1,088,000,000) |  | 0 |  | 0 |  | 0 |  | 0 |  | 0 |  | (1,088,000,000) |
Sale or cancellation of treasury shares | [5] |  |  | 0 |  | 0 |  | 0 |  | 0 |  | 13,000,000 |  | 0 |  | 0 |  | 1,322,000,000 |  | 0 |  | 0 |  | 0 |  | 0 |  | 0 |  | 1,335,000,000 |
Reclassification of financial liabilities to other equity instruments | [5] |  |  | 0 |  | 0 |  | 0 |  | 0 |  | 0 |  | 0 |  | 0 |  | 0 |  | 0 |  | 0 |  | 0 |  | 0 |  | 0 |  | 0 |
Reclassification of other equity instruments to financial liabilities | [5] |  |  | 0 |  | 0 |  | 0 |  | 0 |  | 0 |  | 0 |  | 0 |  | 0 |  | 0 |  | 0 |  | 0 |  | 0 |  | 0 |  | 0 |
Transfers between total equity entries | [5] |  |  | 0 |  | 0 |  | 0 |  | 0 |  | 4,364,000,000 |  | (3,000,000) |  | (70,000,000) |  | 0 |  | (5,400,000,000) |  | 1,109,000,000 |  | 0 |  | 0 |  | 0 |  | 0 |
Increase/Reduction of equity due to business combinations | [5] |  |  | 0 |  | 0 |  | 0 |  | 0 |  | 0 |  | 0 |  | 0 |  | 0 |  | 0 |  | 0 |  | 0 |  | 0 |  | 0 |  | 0 |
Share based payments | [5] |  |  | 0 |  | 0 |  | 0 |  | (4,000,000) |  | 0 |  | 0 |  | 0 |  | 0 |  | 0 |  | 0 |  | 0 |  | 0 |  | 0 |  | (4,000,000) |
Other increases or (-) decreases in equity | [5] |  |  | 0 |  | 0 |  | 0 |  | 11,000,000 |  | 13,000,000 |  | 0 |  | (13,000,000) |  | 0 |  | 0 |  | 0 |  | 0 |  | 0 |  | 27,000,000 |  | 38,000,000 |
Balance at the end at Dec. 31, 2019 |  | 54,925,000,000 |  | 3,267,000,000 | [1],[6] | 23,992,000,000 | [1],[6] | 0 | [1],[6] | 56,000,000 | [1],[6] | 26,402,000,000 | [1],[6] | 0 | [1],[6] | (125,000,000) | [1],[6] | (62,000,000) | [1],[6] | 3,512,000,000 | [1],[6] | (1,084,000,000) | [1],[6] | (7,235,000,000) | [1],[6] | (3,526,000,000) | [1],[6] | 9,727,000,000 | [1],[6] | 54,925,000,000 | [1],[6]
Changes in Equity Abstract |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Adjustments Of Accounting Policies Applications |  |  |  | 0 |  | 0 |  | 0 |  | 0 |  | 2,985,000,000 |  | 0 |  | 6,000,000 |  | 0 |  | 0 |  | 0 |  | (2,992,000,000) |  | (2,045,000,000) |  | 2,045,000,000 |  | 0 |
TOTAL RECOGNIZED INCOME/EXPENSES |  | (3,315,000,000) |  | 0 |  | 0 |  | 0 |  | 0 |  | 0 |  | 0 |  | 0 |  | 0 |  | 1,305,000,000 |  | 0 |  | (4,013,000,000) |  | (1,362,000,000) |  | 756,000,000 |  | (3,315,000,000) |
Changes in equity |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Total Changes in Equity |  |  |  | 0 |  | 0 |  | 0 |  | (14,000,000) |  | 1,120,000,000 |  | 0 |  | (45,000,000) |  | 16,000,000 |  | (3,512,000,000) |  | 1,084,000,000 |  | (116,000,000) |  | (16,000,000) |  | (107,000,000) |  | (1,590,000,000) |
Issue Of Equity |  |  |  | 0 |  | 0 |  | 0 |  | 0 |  | 0 |  | 0 |  | 0 |  | 0 |  | 0 |  | 0 |  | 0 |  | 0 |  | 0 |  | 0 |
Issuances of preferred shares |  |  |  | 0 |  | 0 |  | 0 |  | 0 |  | 0 |  | 0 |  | 0 |  | 0 |  | 0 |  | 0 |  | 0 |  | 0 |  | 0 |  | 0 |
Issuance of other equity instruments |  |  |  | 0 |  | 0 |  | 0 |  | 0 |  | 0 |  | 0 |  | 0 |  | 0 |  | 0 |  | 0 |  | 0 |  | 0 |  | 0 |  | 0 |
Period or maturity of other issued equity instruments |  |  |  | 0 |  | 0 |  | 0 |  | 0 |  | 0 |  | 0 |  | 0 |  | 0 |  | 0 |  | 0 |  | 0 |  | 0 |  | 0 |  | 0 |
Conversion of debt on equity |  |  |  | 0 |  | 0 |  | 0 |  | 0 |  | 0 |  | 0 |  | 0 |  | 0 |  | 0 |  | 0 |  | 0 |  | 0 |  | 0 |  | 0 |
Common Stock reduction |  |  |  | 0 |  | 0 |  | 0 |  | 0 |  | 0 |  | 0 |  | 0 |  | 0 |  | 0 |  | 0 |  | 0 |  | 0 |  | 0 |  | 0 |
Dividend distribution |  |  |  | 0 |  | 0 |  | 0 |  | 0 |  | (1,065,000,000) |  | 0 |  | 0 |  | 0 |  | 0 |  | 0 |  | 0 |  | 0 |  | (124,000,000) |  | (1,190,000,000) |
Purchase of treasury shares |  |  |  | 0 |  | 0 |  | 0 |  | 0 |  | 0 |  | 0 |  | 0 |  | (807,000,000) |  | 0 |  | 0 |  | 0 |  | 0 |  | 0 |  | (807,000,000) |
Sale or cancellation of treasury shares |  |  |  | 0 |  | 0 |  | 0 |  | 0 |  | 0 |  | 0 |  | 0 |  | 823,000,000 |  | 0 |  | 0 |  | 0 |  | 0 |  | 0 |  | 822,000,000 |
Reclassification of financial liabilities to other equity instruments |  |  |  | 0 |  | 0 |  | 0 |  | 0 |  | 0 |  | 0 |  | 0 |  | 0 |  | 0 |  | 0 |  | 0 |  | 0 |  | 0 |  | 0 |
Reclassification of other equity instruments to financial liabilities |  |  |  | 0 |  | 0 |  | 0 |  | 0 |  | 0 |  | 0 |  | 0 |  | 0 |  | 0 |  | 0 |  | 0 |  | 0 |  | 0 |  | 0 |
Transfers between total equity entries |  |  |  | 0 |  | 0 |  | 0 |  | 0 |  | 2,585,000,000 |  | 0 |  | (40,000,000) |  | 0 |  | (3,512,000,000) |  | 1,084,000,000 |  | (116,000,000) |  | (16,000,000) |  | 16,000,000 |  | 0 |
Increase/Reduction of equity due to business combinations |  |  |  | 0 |  | 0 |  | 0 |  | 0 |  | 0 |  | 0 |  | 0 |  | 0 |  | 0 |  | 0 |  | 0 |  | 0 |  | 0 |  | 0 |
Share based payments |  |  |  | 0 |  | 0 |  | 0 |  | (22,000,000) |  | 0 |  | 0 |  | 0 |  | 0 |  | 0 |  | 0 |  | 0 |  | 0 |  | 0 |  | (22,000,000) |
Other increases or (-) decreases in equity |  |  |  | 0 |  | 0 |  | 0 |  | 8,000,000 |  | (399,000,000) |  | 0 |  | (4,000,000) |  | 0 |  | 0 |  | 0 |  | 0 |  | 0 |  | 1,000,000 |  | (394,000,000) |
Balance at the end at Dec. 31, 2020 |  | € 50,020,000,000 |  | € 3,267,000,000 | [7] | € 23,992,000,000 | [7] | € 0 | [7] | € 42,000,000 | [7] | € 30,508,000,000 | [7] | € 0 | [7] | € (164,000,000) | [7] | € (46,000,000) | [7] | € 1,305,000,000 | [7] | € 0 | [7] | € (14,356,000,000) | [7] | € (6,949,000,000) | [7] | € 12,421,000,000 | [7] | € 50,020,000,000 | [7]
[1] | (*) Restated due to the sale of the stake in BBVA USA (see Notes 3 and 21).
[2] | (*) Restated due to the sale of the stake in BBVA USA (see Notes 3 and 21).
[3] | (*) Restated due to the sale of the stake in BBVA USA (see Notes 3 and 21).
[4] | (**) Balances as of December 31, 2017 as originally reported in the consolidated Financial Statements for the year 2017.
[5] | (*) Restated due to the sale of the stake in BBVA USA (see Notes 3 and 21).
[6] | (**) Balances as of December 31, 201 8 as originally reported in the consolidated Financial Statements for the year 2018.
[7] | (*) Balances as of December 31, 201 9 as originally reported in the consolidated Financ ial Statements for the year 2019 .

X
- References No definition available. + Details
Name: | bbva_Adjustmentsofaccountingpoliciesapplications
Namespace Prefix: | bbva_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- References No definition available. + Details
Name: | bbva_Changesequityabstract
Namespace Prefix: | bbva_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The amount of changes in equity due to the issuance of other equity instruments. The cash inflow from the issuing of other equity instruments + References No definition available. + Details
Name: | bbva_Issueofotherequityinstruments
Namespace Prefix: | bbva_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition The amount of changes in equity due to the issuance of preferred shares. The cash inflow from the issuing of preference shares. [Refer: Preference shares [member]] + References No definition available. + Details
Name: | bbva_Issueofpreferredshares
Namespace Prefix: | bbva_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition The amount of changes in equity due to the maturity of issued equity instruments. The amount corresponding to the settlement or maturity of other equity instruments issued + References No definition available. + Details
Name: | bbva_Periodormaturityoftheirissuedequityinstruments
Namespace Prefix: | bbva_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition The amount of changes in equity due to the reclassification of financial liabilities into equity instruments. + References No definition available. + Details
Name: | bbva_Reclassificationoffinancialliabilitiestootherequityinstruments
Namespace Prefix: | bbva_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition The amount of changes in equity due to the reclassification of financial liabilities into equity instruments. + References No definition available. + Details
Name: | bbva_Reclassificationofotherequityinstrumentstofinancialliabilities
Namespace Prefix: | bbva_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition The total amount of changes in equity that have occured in the reporting perido. The increase (decrease) in equity. [Refer: Equity] + References No definition available. + Details
Name: | bbva_Totalchangesinequity
Namespace Prefix: | bbva_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- References No definition available. + Details
Name: | ifrs-full_ChangesInEquityAbstract
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The amount of change in equity resulting from transactions and other events, other than those changes resulting from transactions with owners in their capacity as owners. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Name IFRS -Number 1 -IssueDate 2020-01-01 -Paragraph 32 -Subparagraph a -Clause ii -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=1&code=ifrs-tx-2020-en-r&anchor=para_32_a_ii&doctype=Standard -URIDate 2020-01-01 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Name IFRS -Number 1 -IssueDate 2020-01-01 -Paragraph 24 -Subparagraph b -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=1&code=ifrs-tx-2020-en-r&anchor=para_24_b&doctype=Standard -URIDate 2020-01-01 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Name IFRS -Number 12 -IssueDate 2020-01-01 -Paragraph B12 -Subparagraph b -Clause ix -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2020-en-r&anchor=para_B12_b_ix&doctype=Appendix&subtype=B -URIDate 2020-01-01 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Name IAS -Number 1 -IssueDate 2020-01-01 -Paragraph 106 -Subparagraph a -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2020-en-r&anchor=para_106_a&doctype=Standard -URIDate 2020-01-01 Reference 5: http://www.xbrl.org/2003/role/exampleRef -Name IFRS -Number 12 -IssueDate 2020-01-01 -Paragraph B10 -Subparagraph b -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2020-en-r&anchor=para_B10_b&doctype=Appendix&subtype=B -URIDate 2020-01-01 Reference 6: http://www.xbrl.org/2003/role/disclosureRef -Name IAS -Number 1 -IssueDate 2020-01-01 -Paragraph 81A -Subparagraph c -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2020-en-r&anchor=para_81A_c&doctype=Standard -URIDate 2020-01-01 + Details
Name: | ifrs-full_ComprehensiveIncome
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition The amount of dividends recognised as distributions to owners. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Name IAS -Number 1 -IssueDate 2020-01-01 -Paragraph 107 -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2020-en-r&anchor=para_107&doctype=Standard -URIDate 2020-01-01 + Details
Name: | ifrs-full_DividendsPaid
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition The amount of residual interest in the assets of the entity after deducting all its liabilities. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Name IFRS -Number 1 -IssueDate 2020-01-01 -Paragraph 24 -Subparagraph a -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=1&code=ifrs-tx-2020-en-r&anchor=para_24_a&doctype=Standard -URIDate 2020-01-01 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Name IFRS -Number 1 -IssueDate 2020-01-01 -Paragraph 32 -Subparagraph a -Clause i -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=1&code=ifrs-tx-2020-en-r&anchor=para_32_a_i&doctype=Standard -URIDate 2020-01-01 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Name IFRS -Number 13 -IssueDate 2020-01-01 -Paragraph 93 -Subparagraph a -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=13&code=ifrs-tx-2020-en-r&anchor=para_93_a&doctype=Standard -URIDate 2020-01-01 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Name IFRS -Number 13 -IssueDate 2020-01-01 -Paragraph 93 -Subparagraph b -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=13&code=ifrs-tx-2020-en-r&anchor=para_93_b&doctype=Standard -URIDate 2020-01-01 Reference 5: http://www.xbrl.org/2003/role/disclosureRef -Name IFRS -Number 13 -IssueDate 2020-01-01 -Paragraph 93 -Subparagraph e -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=13&code=ifrs-tx-2020-en-r&anchor=para_93_e&doctype=Standard -URIDate 2020-01-01 Reference 6: http://www.xbrl.org/2003/role/disclosureRef -Name IAS -Number 1 -IssueDate 2020-01-01 -Paragraph 55 -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2020-en-r&anchor=para_55&doctype=Standard -URIDate 2020-01-01 Reference 7: http://www.xbrl.org/2003/role/disclosureRef -Name IAS -Number 1 -IssueDate 2020-01-01 -Paragraph 78 -Subparagraph e -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2020-en-r&anchor=para_78_e&doctype=Standard -URIDate 2020-01-01 + Details
Name: | ifrs-full_Equity
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Definition The increase (decrease) in equity resulting from the acquisition of subsidiaries. [Refer: Subsidiaries [member]] + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Name IAS -Number 1 -IssueDate 2020-01-01 -Paragraph 106 -Subparagraph d -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2020-en-r&anchor=para_106_d&doctype=Standard -URIDate 2020-01-01 + Details
Name: | ifrs-full_IncreaseDecreaseThroughAcquisitionOfSubsidiary
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition The increase (decrease) in equity resulting from the conversion of convertible instruments. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Name IAS -Number 1 -IssueDate 2020-01-01 -Paragraph 106 -Subparagraph d -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2020-en-r&anchor=para_106_d&doctype=Standard -URIDate 2020-01-01 + Details
Name: | ifrs-full_IncreaseDecreaseThroughConversionOfConvertibleInstruments
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition The decrease in equity through distributions to owners that the entity does not separately disclose in the same statement or note. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Name IAS -Number 1 -IssueDate 2020-01-01 -Paragraph 106 -Subparagraph d -Clause iii -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2020-en-r&anchor=para_106_d_iii&doctype=Standard -URIDate 2020-01-01 + Details
Name: | ifrs-full_IncreaseDecreaseThroughOtherDistributionsToOwners
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition The increase (decrease) in equity resulting from share-based payment transactions. [Refer: Equity] + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Name IAS -Number 1 -IssueDate 2020-01-01 -Paragraph 106 -Subparagraph d -Clause iii -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2020-en-r&anchor=para_106_d_iii&doctype=Standard -URIDate 2020-01-01 + Details
Name: | ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition The increase (decrease) in equity resulting from transactions with owners. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Name IAS -Number 1 -IssueDate 2020-01-01 -Paragraph 106 -Subparagraph d -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2020-en-r&anchor=para_106_d&doctype=Standard -URIDate 2020-01-01 + Details
Name: | ifrs-full_IncreaseDecreaseThroughTransactionsWithOwners
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition The increase (decrease) in equity resulting from changes that the entity does not separately disclose in the same statement or note. [Refer: Equity] + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Name IAS -Number 1 -IssueDate 2020-01-01 -Paragraph 106 -Subparagraph d -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2020-en-r&anchor=para_106_d&doctype=Standard -URIDate 2020-01-01 + Details
Name: | ifrs-full_IncreaseDecreaseThroughTransfersAndOtherChangesEquity
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition The increase in equity through the issue of equity instruments. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Name IAS -Number 1 -IssueDate 2020-01-01 -Paragraph 106 -Subparagraph d -Clause iii -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2020-en-r&anchor=para_106_d_iii&doctype=Standard -URIDate 2020-01-01 + Details
Name: | ifrs-full_IssueOfEquity
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition The decrease in equity resulting from the purchase of treasury shares. [Refer: Treasury shares] + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Name IAS -Number 1 -IssueDate 2020-01-01 -Paragraph 106 -Subparagraph d -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2020-en-r&anchor=para_106_d&doctype=Standard -URIDate 2020-01-01 + Details
Name: | ifrs-full_PurchaseOfTreasuryShares
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition The increase in equity resulting from the sale or issue of treasury shares. [Refer: Treasury shares] + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Name IAS -Number 1 -IssueDate 2020-01-01 -Paragraph 106 -Subparagraph d -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2020-en-r&anchor=para_106_d&doctype=Standard -URIDate 2020-01-01 + Details
Name: | ifrs-full_SaleOrIssueOfTreasuryShares
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration